Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
Yang Liu, Weiming MaoDepartment of Cell Biology and Anatomy, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TXAbstract: Glaucoma is a leading cause of visual loss worldwide. Current antiglaucoma therapy focuses on lowering intraocular pressure to a s...
Main Authors: | Liu Y, Mao W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-12-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/tafluprost-once-daily-for-treatment-of-elevated-intraocular-pressure-i-a11812 |
Similar Items
-
Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
by: Dorota Pozarowska
Published: (2010-10-01) -
Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
by: Makoto Aihara
Published: (2010-03-01) -
Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
by: Clyde Schultz
Published: (2011-06-01) -
Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
by: Clyde Schultz
Published: (2011-01-01) -
Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
by: Janulevičienė I, et al.
Published: (2012-01-01)